Taken together, these data suggest that CoQ0 treatment also promotes cell growth inhibition by inducing G1/S transition phase arrest, followed by the down-regulation of cyclin D1/E and CDK4 expression in melanoma cells. The gene discussed is CCND1; the disease is melanoma.